IQ CBRE NextGen Real Estate ETF (ROOF) Chart & Stock Price History → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ROOF Stock Alerts $18.25 +0.05 (+0.27%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings IQ CBRE NextGen Real Estate ETF Stock Price Performance5 Day Performance-2.75%1 Month Performance-5.57%3 Month Performance-6.68%6 Month Performance+7.82%Year-To-Date Performance-10.66%1 Year Performance-6.06% Receive ROOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IQ CBRE NextGen Real Estate ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! ROOF Stock Chart for Friday, April, 19, 2024 ROOF Chart by TradingView IQ CBRE NextGen Real Estate ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024$18.20$18.25+0.27%$18.29$18.25505 shs$136.88 million04/18/2024$18.22$18.20-0.11%$18.26$18.14706 shs$136.50 million04/17/2024$18.38$18.22-0.87%$18.25$18.211,532 shs$136.65 million04/16/2024$18.55$18.38-0.92%$18.41$18.38344 shs$137.85 million04/15/2024$18.77$18.55-1.17%$18.55$18.55328 shs$139.13 million04/12/2024$19.06$18.77-1.52%$18.82$18.771,820 shs$140.78 million Get the Latest News and Ratings for ROOF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IQ CBRE NextGen Real Estate ETF and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024$19.06$19.06$19.08$19.06370 shs$20.97 million04/10/2024$19.64$19.06-2.95%$19.06$19.00253 shs$20.97 million04/09/2024$19.40$19.64+1.24%$19.64$19.4865,982 shs$21.60 million04/08/2024$19.21$19.40+0.97%$19.40$19.301,222 shs$21.34 million04/05/2024$19.09$19.21+0.63%$19.22$19.101,083 shs$21.13 million04/04/2024$19.19$19.09-0.52%$19.42$19.095,433 shs$21.00 million04/03/2024$19.19$19.19$19.24$19.19578 shs$21.11 million04/02/2024$19.41$19.19-1.13%$19.31$19.1811,114 shs$21.11 million04/01/2024$19.73$19.41-1.63%$19.51$19.412,696 shs$21.35 million03/29/2024$19.72$19.73+0.06%$19.73$19.65680 shs$21.71 million03/28/2024$19.60$19.72+0.61%$19.72$19.72582 shs$21.69 million03/27/2024$19.24$19.60+1.87%$19.60$19.482,187 shs$21.56 million03/26/2024$19.34$19.24-0.52%$19.41$19.241,383 shs$21.16 million03/25/2024$19.39$19.34-0.26%$19.41$19.341,259 shs$21.27 million03/22/2024$19.55$19.39-0.82%$19.58$19.39875 shs$21.33 million03/21/2024$19.45$19.55+0.51%$19.62$19.531,361 shs$21.51 million03/20/2024$19.33$19.45+0.62%$19.45$19.252,493 shs$21.40 million03/19/2024$19.29$19.33+0.21%$19.37$19.32649 shs$21.26 million03/18/2024$19.36$19.29-0.36%$19.38$19.292,742 shs$21.22 million03/15/2024$19.48$19.36-0.62%$19.40$19.31558 shs$21.30 million03/14/2024$19.70$19.48-1.12%$19.69$19.39862 shs$21.43 million03/13/2024$19.78$19.70-0.40%$19.85$19.70697 shs$21.67 million03/12/2024$19.91$19.78-0.65%$19.87$19.77757 shs$21.76 million03/11/2024$20.01$19.91-0.48%$19.95$19.9182,859 shs$21.90 million03/08/2024$19.82$20.02+0.98%$20.02$20.02708 shs$22.02 million03/07/2024$19.78$19.82+0.20%$19.91$19.775,033 shs$21.80 million03/06/2024$19.88$19.78-0.50%$19.78$19.76981 shs$21.76 million03/05/2024$19.79$19.88+0.44%$19.88$19.602,109 shs$21.87 million03/04/2024$19.61$19.79+0.94%$19.80$19.5613,812 shs$21.77 million03/01/2024$19.34$19.61+1.40%$19.61$19.403,213 shs$21.57 million02/29/2024$19.19$19.34+0.76%$19.38$19.253,518 shs$21.27 million02/28/2024$19.05$19.19+0.75%$19.19$19.12236 shs$21.11 million02/27/2024$19.12$19.05-0.37%$19.16$19.016,295 shs$20.96 million02/26/2024$19.32$19.12-1.04%$19.12$19.101,540 shs$21.03 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/23/2024$19.38$19.32-0.29%$19.35$19.32698 shs$21.25 million02/22/2024$19.28$19.38+0.50%$19.38$19.298,857 shs$21.32 million02/21/2024$19.23$19.28+0.26%$19.28$19.163,333 shs$21.21 million02/20/2024$19.18$19.23+0.26%$19.27$19.165,055 shs$21.15 million02/19/2024$19.18$19.18$19.26$19.181,700 shs$21.10 million02/16/2024$19.41$19.18-1.18%$19.26$19.181,772 shs$21.10 million02/15/2024$19.02$19.41+2.07%$19.41$19.121,040 shs$21.35 million02/14/2024$18.80$19.02+1.15%$19.04$18.936,422 shs$20.92 million02/13/2024$19.23$18.80-2.22%$18.89$18.704,534 shs$20.68 million02/12/2024$19.21$19.23+0.09%$19.27$19.22199,232 shs$21.15 million02/09/2024$19.18$19.21+0.16%$19.21$19.07804 shs$21.13 million02/08/2024$19.03$19.18+0.79%$19.21$19.054,732 shs$21.10 million02/07/2024$19.15$19.03-0.63%$19.18$19.023,077 shs$20.93 million02/06/2024$18.99$19.15+0.84%$19.16$18.972,649 shs$21.07 million02/05/2024$19.36$18.99-1.91%$19.13$18.982,081 shs$20.89 million02/02/2024$19.52$19.36-0.82%$19.41$19.132,256 shs$21.30 million02/01/2024$19.25$19.52+1.40%$19.52$19.152,162 shs$21.47 million01/31/2024$19.37$19.25-0.62%$19.56$19.25916 shs$21.18 million01/30/2024$19.52$19.37-0.77%$19.44$19.352,951 shs$21.31 million01/29/2024$19.42$19.52+0.51%$19.52$19.401,422 shs$21.47 million01/26/2024$19.45$19.40-0.26%$19.42$19.402,302 shs$21.34 million01/25/2024$19.30$19.45+0.78%$19.51$19.396,548 shs$21.40 million01/24/2024$19.53$19.30-1.18%$19.74$19.29729 shs$21.23 million01/23/2024$19.71$19.53-0.89%$19.72$19.481,223 shs$21.48 million01/22/2024$19.56$19.71+0.74%$19.71$19.652,956 shs$21.68 million01/19/2024$19.35$19.56+1.09%$19.61$19.3919,022 shs$21.52 million01/18/2024$19.52$19.35-0.87%$19.35$19.34823 shs$21.29 million Related Companies: PPTY Stock Chart RSPR Stock Chart FRI Stock Chart IFGL Stock Chart SPRE Stock Chart EWRE Stock Chart DRV Stock Chart KBWY Stock Chart PFFR Stock Chart SRET Stock Chart Receive ROOF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for IQ CBRE NextGen Real Estate ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:ROOF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQ CBRE NextGen Real Estate ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.